MRSN - Mersana Therapeutics GAAP EPS of -$0.16 beats by $0.02 revenue of $9.25M beats by $0.75M
2024-05-09 07:21:47 ET
More on Mersana Therapeutics
- Mersana Therapeutics, Inc. (MRSN) Q4 2023 Earnings Call Transcript
- Mersana Therapeutics Q1 2024 Earnings Preview
- Mersana Therapeutics GAAP EPS of -$0.16 in-line, revenue of $10.7M misses by $4.07M
- Seeking Alpha’s Quant Rating on Mersana Therapeutics
- Historical earnings data for Mersana Therapeutics